Stuart – How to Get on the Boards You Want
Join us for a panel discussion with outstanding female leaders in the biotech sector. We have Christos Richards (of Spencer Stuart’s BioPharma practice in Los Angeles) leading our panel with insights into current trends in biotech board recruitment, joined by Barbara Duncan, Arlene Morris, and Karah Parschauer who sit on a total of ten public company boards in the U.S. and Europe currently. Hear their advice and how they are navigating the COVID-19 pandemic.
Barbara Duncan serves as a
Director of Adaptimmune Therapeutics plc, Immunomedics, Inc., Jounce
Therapeutics, Inc., ObsEva plc and Ovid Therapeutics, Inc. . Ms. Duncan served
as the chief financial officer of Intercept Pharmaceuticals Inc. from 2009 to
2016 and as treasurer from 2010 to 2016. From 2001 to 2009, Ms. Duncan served
as chief financial officer and then chief executive officer at DOV
Pharmaceutical, Inc. Previously, Ms. Duncan served as a vice president of
Lehman Brothers Inc. in its corporate finance division from 1998 to 2001. She
serves on the board of directors.
Ms. Duncan holds a B.S. degree from Louisiana State University and an M.B.A from the Wharton School.